Amplitude, Genesys lead Giiant Pharma’s $11m seed deal

Montreal-based Giiant Pharma, developer of a precision delivery technology platform in gastroenterology, has secured $11 million (C$13.5 million) in a seed financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this